MedDRA : Safety Data Analysis and SMQs

Similar documents
Use of MedDRA in CTCAE and in the Biopharmaceutical Industry

Medical Dictionary for Regulatory Activities (MedDRA) Update

Standardised MedDRA Queries (SMQs)

Coding with MedDRA. MedDRA and the MSSO

Introduction to MedDRA Data Analysis and SMQs for Physicians

Implemented MedDRA Version 19.0 Complex Changes (October 2015)

MedDRA Coding Basics

MedDRA in clinical trials industry perspective

Coding with Confidence

Understanding MedDRA The Medical Dictionary for Regulatory Activities

Sonja Brajovic, M.D. Medical Officer, Office of Surveillance and Epidemiology Center for Drug Evaluation and Research Food and Drug Administration

The Roles of the MSSO and the JMO Mr. Patrick Revelle Director MedDRA Maintenance and Support Services Organization Northrop Grumman

MedDRA in pharmacovigilance industry perspective

How To Classify Medical Terms

FULL DESCRIPTION OF QUARTERWATCH METHODOLOGY

MedDRA 9.1 Review. MedDRA Version Changes - General Remarks. MedDRA 9.1 Changes Overview. MedDRA Version 9.1 Terminology Frequency Distribution

How to search the EU Clinical Trials Register

A.P. Chen, MD Director, Developmental Therapeutics Clinic Division of Cancer Treatment and Diagnosis National Cancer Institute

Introductory Guide MedDRA Version 18.0

MEDICAL POLICY No R7 DETOXIFICATION I. POLICY/CRITERIA

ICD-9-CM to MedDRA Mapping How Well Do the. Disclaimer

Questions and answers on serious non-fatal adverse events and reporting rules

Introductory Guide for Standardised MedDRA Queries (SMQs) Version 15.0

Versioning in Clinical Trials. European Industry MedDRA User Group Meeting March 28 th 2014 Vienna

MedDRA TERM SELECTION: POINTS TO CONSIDER

Adverse Events in Clinical Trials: Definitions and Documentation

F.E.E.A. FONDATION EUROPEENNE D'ENSEIGNEMENT EN ANESTHESIOLOGIE FOUNDATION FOR EUROPEAN EDUCATION IN ANAESTHESIOLOGY

EUROPEAN MEDICINES PRACTICES AND TOOLS AGENCY DRUG SAFETY

Pharmacovigilance Review

Sponsor Novartis. Generic Drug Name Secukinumab. Therapeutic Area of Trial Psoriasis. Approved Indication investigational

Risk Management Plan

Automatic External Defibrillators

March 31, Etiometry, Inc. Richard Galgon Independent Consulting Associate Quintiles 5846 Cobblestone Lane Waunakee, Wisconsin 53597

PHC4 35 Diseases, Procedures, and Medical Conditions for which Laboratory Data is Required Effective 10/1/2015

MedDRA TERM SELECTION: POINTS TO CONSIDER

ECG may be indicated for patients with cardiovascular risk factors

Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole)

Risk Management Plan (RMP) Guidance (Draft)

EXHIBIT H SETTLEMENT ELIGIBILITY CRITERIA. a) pharmacy records reflecting the dispensing of Bextra and/or Celebrex to the Class Member; or

Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout.

Preoperative Laboratory and Diagnostic Studies

Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC

Overview. Geriatric Overview. Chapter 26. Geriatrics 9/11/2012

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Breaking the Code: ICD-9-CM Coding in Details

Summary of the risk management plan (RMP) for Cerdelga (eliglustat)

Medicare Advantage Risk Adjustment Data Validation CMS-HCC Pilot Study. Report to Medicare Advantage Organizations

Drug Analysis Print Drug name: MONOCLONAL ANTIBODY SM3

2FORMATS AND CONVENTIONS

Professional Certificate in Primary Care Psychology

Sixth pandemic pharmacovigilance weekly update

Can Coding MedDRA and WHO Drug be as Easy as a Google Search? Sy Truong, Meta-Xceed, Inc., Milpitas, CA Na Li, Pharmacyclics, Sunnyvale CA

Medicines Management

Hospital-based SNF Coding Tip Sheet: Top 25 codes and ICD-10 Chapter Overview

Influenza Vaccine Protocol Agreement (O.C.G.A. Section )

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

Introduction to ICD Andrea Devlin, CPMA, CPC Alta Partners, LLC 2015

Cardiovascular Disease and Maternal Mortality what do we know and what are the key questions?

U.S. Department of Health and Human Services Food and Drug Administration Center for Food Safety and Applied Nutrition

Biogen Idec Contacts: Media: Amy Brockelman (617) Investor: Eric Hoffman (617)

STUDY GUIDE 1.1: NURSING DIAGNOSTIC STATEMENTS AND COMPREHENSIVE PLANS OF CARE

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses

NORTH WALES CRITICAL CARE NETWORK

Salbutamol 1mg/ml Nebuliser Solution. Salbutamol 2mg/ml Nebuliser Solution PL 36390/0035 PL 36390/0036

Patient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust.

Adopted by CHMP in November Revision 1.0 adopted by CHMP on 25 June 2009

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

ACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767

How To Improve A Hospital'S Performance

Adult Chemotherapy Induced Anaphylaxis Policy

Using the ICD-10-CM. The Alphabetic Index helps you determine which section to refer to in the Tabular List. It does not always provide the full code.

IMPORTANT DRUG WARNING Regarding Mycophenolate-Containing Products

ACLS PHARMACOLOGY 2011 Guidelines

Introduction to Post marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER

Over 660 Contact Hours of Online Continuing Nursing Education!

Good practice guide on recording, coding, reporting and assessment of medication errors

patient group direction

Lidocaine 2% w/v solution for injection Summary of Product Characteristics

Disability Evaluation Under Social Security

Irish Wolfhound Pedigree Breed Health Survey

Anaphylaxis and other adverse events

Drug Analysis Print Drug name: LIOTHYRONINE

The new Heart Failure pathway

White, circular, biconvex, uncoated tablets with a score line on one side, plain on the other.

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

Ch. 138 CARDIAC CATHETERIZATION SERVICES CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Tachyarrhythmias (fast heart rhythms)

Clinical Performance Director of Nursing Allison Bussey

Inpatient Heart Failure Management: Risks & Benefits

PATIENT CARE TECHNICIAN

Universitätsklinik für Kardiologie. Test. Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie 1

Selective IgA deficiency (slgad)

Adverse Events Following Immunisation (AEFI) Noel McCarthy Thames Valley Public Health England Centre and Everybody

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013.

INDIVIDUAL LIFE INSURANCE APPLICATION PART II - MEDICAL EXAMINATION

ICD 10 is here!!! Getting Ready for ICD-10: Cracking the Code. CPT vs ICD. Definitions. WHY do we have to use these codes?

Elements for a Public Summary

Transcription:

MedDRA : Safety Data Analysis and SMQs MedDRA Data Retrieval and Presentation: Points to Consider An ICH-Endorsed Guide for MedDRA users on Data Output Developed by an ICH Expert Working Group Provides data retrieval and presentation options for industry or regulatory purposes Objective is to promote understanding of implications that various options for data retrieval have on accuracy and consistency of final output Current version available on MedDRA MSSO Web site (http://www.meddramsso.com/mssoweb/activities/ptc.htm) 2

Data Retrieval PTC Points Addressed Quality of source data Documentation of data retrieval and presentation practices Organization-specific data characteristics Characteristics of MedDRA that impact data retrieval and Presentation MedDRA versioning General queries and retrieval Standardised MedDRA Queries Customized searches 3 Quality of Source Data High quality data output is dependent on maintaining quality of original information reported by using consistent and appropriate term selection (Refer to MedDRA Term Selection: Points to Consider document) Method of conversion of data into MedDRA might impact retrieval and presentation - legacy data conversion using verbatims or coded terms 4

Documentation of Data Retrieval and Presentation Practices Organization-specific guidelines Consistent with Points to Consider documents Coding conventions Data retrieval and output strategies (including SMQs) Versioning update process QA procedures Review by individuals with medical background and MedDRA training MedDRA is standardized and SOC assignments are pre-determined; no ad hoc structural alterations 5 Organization-Specific Data Characteristics Database structure Data storage Data migration Coding practices over time Limitations/restrictions (inability to view secondary SOCs) Term selection principles More than one term selected increases counts Diagnosis term only selected reduces counts 6

Impact of MedDRA s Characteristics Grouping Terms HLGTs and HLTs provide clinically relevant groupings HLGT Cardiac arrhythmias HLT Cardiac conduction disorders HLT Rate and rhythm disorders NEC HLT Supraventricular arrhythmias HLT Ventricular arrhythmias and cardiac arrest 7 Impact of MedDRA s Characteristics Grouping Terms (cont) Caution - ensure all terms are relevant to output HLT Vascular tests NEC (incl blood pressure) PT Blood pressure decreased PT Blood pressure increased Caution - related PTs in different locations in SOC HLT Bullous conditions PT Stevens-Johnson syndrome HLT Exfoliative conditions PT Dermatitis exfoliative 8

Granularity Other Terminology Preferred Terms # of Subj MedDRA Version 12.0 Preferred Terms #of Subj INFECTION 12 Upper respiratory tract infection Nasopharyngitis Localised infection Lower respiratory tract infection Nonspecific reaction 7 2 1 1 1 9 Multi-Axiality Primary SOC allocation rules affect the way data are distributed across the terminology Impact on frequencies of medical condition of interest should be considered Example: for hepatic abnormality search in SOC Hepatobiliary disorders, SOC Investigations (laboratory test terms), SOC Surgical and medical procedures (e.g., PT Liver transplant) 10

MedDRA Versioning MedDRA is updated twice a year 1 March X.0 release (all levels) 1 September X.1 release (LLT and PT levels only) Version used in data retrieval and presentation should be documented Resources: What s New document Version report Terms used for queries should be in same version as data being queried MSSO-DI-6288-11.1.0 2008 Northrop Grumman Corporation. All Rights Reserved. 11 MedDRA Versioning (cont) - Effect of Primary SOC Change MedDRA Version 11.1 Number of Events SOC General disorders and administration site conditions PT Peripheral coldness 20 MedDRA Version 12.0 Number of Events SOC General disorders and administration site conditions SOC Vascular disorders PT Peripheral coldness 0 20 MSSO-DI-6288-11.1.0 2008 Northrop Grumman Corporation. All Rights Reserved. 12

Overall Presentation of Safety Profiles Highlight overall distribution of ADRs/AEs Identify areas for in-depth analysis (focused searches) Approaches: full listing of terms to sophisticated statistical methods Standard approach: present by SOC and PTs This approach not always optimal due to unique characteristics of MedDRA MSSO-DI-6288-11.1.0 2008 Northrop Grumman Corporation. All Rights Reserved. 13 Overview by Primary SOC Use Internationally Agreed Order of SOCs when applicable (see PTC or MedDRA Introductory Guide) Consider use of HLTs and HLGTs for large data sets Line listings, tables, graphs Benefits - Broad overview, PTs displayed only once Limitations - Incomplete groupings, lengthy output MSSO-DI-6288-11.1.0 2008 Northrop Grumman Corporation. All Rights Reserved. 14

Focused Search: Secondary SOC Assignments Query the SOC, HLGT, or HLT to include both primary and secondary SOC assignments in display If database does not allow automated output by secondary SOC, then query should be performed using available processes (e.g., programming a list of all individual PTs in primary and secondary SOC locations). Benefits - more comprehensive view of medically related events Limitations - display by primary and secondary SOC could lead to double counting MSSO-DI-6288-11.1.0 2008 Northrop Grumman Corporation. All Rights Reserved. 15 Standardised MedDRA Queries (SMQs)

Definition of SMQ Result of cooperative effort between CIOMS and ICH (MSSO) Groupings of terms from one or more MedDRA System Organ Classes (SOCs) related to defined medical condition or area of interest Included terms may relate to signs, symptoms, diagnoses, syndromes, physical findings, laboratory and other physiologic test data, etc., related to medical condition or area of interest Intended to aid in case identification 17 SMQs in Production - Examples As of Version 12.0, a total of 74 in production (Other SMQs in development) Adverse pregnancy outcome/reproductive toxicity (incl neonatal disorders) Agranulocytosis Anaphylactic reaction Cerebrovascular disorders Convulsions Depression and suicide/ self-injury Hepatic disorders Ischaemic heart disease Lack of efficacy/effect Peripheral neuropathy Pseudomembranous colitis Rhabdomyolysis/myopathy Severe cutaneous adverse reactions Systemic lupus erythematosus 18

Narrow and Broad Searches Narrow scope specificity (cases highly likely to be condition of interest) Broad scope sensitivity (all possible cases) Broad search = All broad + all narrow terms MedDRA term can be broad or narrow depending on SMQ Example: PT Renal failure acute Narrow in Acute renal failure (SMQ) Broad in Rhabdomyolysis/myopathy (SMQ) Narrow vs. Broad Example Lactic acidosis (SMQ)

Algorithmic SMQs Some SMQs are designed to utilize algorithms Better case identification among broad search terms may result if cases are selected by a defined combination of selected terms Algorithmic SMQ Example Anaphylactic reaction (SMQ): A case with any of the following PTs: Anaphylactic reaction Anaphylactic shock Anaphylactic transfusion reaction Anaphylactoid reaction Anaphylactoid shock Circulatory collapse First use syndrome Kounis syndrome Shock Type I hypersensitivity (Narrow search terms = Category A)

Algorithmic SMQ Example (cont) Category B Upper airway/ Respiratory Category C Angioedema/ Urticaria, etc. Acute respiratory failure Allergic oedema Category D Cardiovascular/ Hypotension Blood pressure decreased Asthma Angioedema Blood pressure diastolic decreased Bronchial oedema Erythema Blood pressure systolic decreased Case = A (Narrow terms) Or Term from Category B and term from Category C Or Term from either Category B or Category C plus Term from Category D Hierarchical SMQs Some SMQs may develop as set of queries related to one another in a hierarchical relationship Not related to MedDRA standard hierarchy One or more subordinate SMQs combined to create a superordinate, more inclusive SMQ

Hierarchical SMQ Example Clinical trials SMQ Applications Where safety profile is not fully established, use multiple SMQs on routine basis as screening tool Selected SMQs to evaluate previously identified issue (pre-clinical data or class effect) Postmarketing Selected SMQs to retrieve cases for suspected or known safety issue Signal detection (multiple SMQs employed) Single case alerts Periodic reporting (aggregate cases for safety and other issues, e.g., lack of efficacy)

Customized Searches Modified SMQs Do not modify SMQ unless there is a compelling reason makes it non-standard Modified MedDRA query based on an SMQ To be used to refer to an SMQ that has been modified All modifications must be documented Version updates and maintenance are responsibility of organization that created it 27 Customized Searches Ad Hoc Queries Need medical knowledge Need knowledge of structure and characteristics of MedDRA and of your data Refer to Data Retrieval and Presentation: Points to Consider document for query construction tips Save query for future use; maintenance needed for MedDRA version changes Consider submitting ad hoc query to MSSO via change request for possible development as an SMQ 28

Mail MedDRA MSSO MSSO Contacts 3975 Virginia Mallory Drive Chantilly, VA, USA 20151 Telephone Toll-free Worldwide 877.258.8280 (AT&T) Fax 703.272.5635 Products and Services Toll-free Worldwide 877.258.8280 (AT&T) MSSO Contacts (cont) To Subscribe by E-mail mssosubscribe@ngc.com Web site www.meddramsso.com click on Subscribe to MedDRA Help desk Phone International AT&T Toll Free: 877.258.8280 Direct Dial (USA): 703.272.5849 E-mail mssohelp@ngc.com